Publication | Open Access

Dantrolene, a Therapeutic Agent for Malignant Hyperthermia, Markedly Improves the Function of Failing Cardiomyocytes by Stabilizing Interdomain Interactions Within the Ryanodine Receptor

Malignant HyperthermiaCardiac MuscleCardiomyopathyHeart FailureMolecular PhysiologyBiochemistryMedicinePhysiologyRyanodine ReceptorInterdomain InteractionsPharmacotherapyPharmacologyCellular PhysiologyDrug DiscoveryOxidative Stress